Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications

被引：1
|
作者：
Low, En Xian Sarah [1 ]
Wang, Yen-Po [1 ,3 ]
Lu, Ching-Liang [1 ,2 ,3 ]
机构：
[1] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Dept Med, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Brain Sci, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Fac Med, Taipei, Taiwan
来源：
DIGESTIVE DISEASES AND SCIENCES | 2024年 / 69卷 / 01期
关键词：
Cirrhosis; Proton pump inhibitors; Hepatocellular carcinoma; Hepatic decompensation; Spontaneous bacterial peritonitis;
D O I：
10.1007/s10620-023-08153-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The use of proton pump inhibitor (PPI) in cirrhotic patients can be associated with increased risks of long-term mortality, decompensation, hepatic encephalopathy, spontaneous bacterial peritonitis, and infection, but not with short-term mortality. Ensure clear indications at lowest effective dose of is mandatory for the use of PPI among cirrhotic patients.
引用
收藏
页码：7 / 9
页数：3
相关论文
共 50 条
  • [21] Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome
    Singh, Amandeep
    Cresci, Gail A.
    Kirby, Donald F.
    NUTRITION IN CLINICAL PRACTICE, 2018, 33 (05) : 614 - 624
  • [22] Proton-pump inhibitors: understanding the complications and risks
    Malfertheiner, Peter
    Kandulski, Arne
    Venerito, Marino
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2017, 14 (12) : 697 - 710
  • [23] Proton Pump Inhibitors in cancer patients: How useful they are? A review of the most common indications for their use
    Numico, Gianmauro
    Fusco, Vittorio
    Franco, Pierfrancesco
    Rolla, Fausto
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 111 : 144 - 151
  • [24] Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis
    Zhu, Jia
    Qi, Xingshun
    Yu, Haonan
    Yoshida, Eric M.
    Mendez-Sanchez, Nahum
    Zhang, Xintong
    Wang, Ran
    Deng, Han
    Li, Jing
    Han, Dan
    Guo, Xiaozhong
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (08) : 1179 - 1187
  • [25] The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients
    Wellhoener, Freya
    Doescher, Nico
    Tergast, Tammo Lambert
    Vital, Marius
    Plumeier, Iris
    Kahl, Silke
    Potthoff, Andrej
    Manns, Michael Peter
    Maasoumy, Benjamin
    Wedemeyer, Heiner
    Cornberg, Markus
    Pieper, Dietmar Helmut
    Heidrich, Benjamin
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (08) : 1033 - 1041
  • [26] Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis
    Nardelli, Silvia
    Gioia, Stefania
    Ridola, Lorenzo
    Farcomeni, Alessio
    Merli, Manuela
    Riggio, Oliviero
    HEPATOLOGY, 2019, 70 (02) : 640 - 649
  • [27] Use of Proton Pump Inhibitors Among Patients With Alcohol-Related Cirrhosis-A Danish Nationwide Cohort Study
    Ramsing, Marine Solling
    Jensen, Morten Daniel
    Jepsen, Peter
    LIVER INTERNATIONAL, 2025, 45 (04)
  • [28] Letter: proton pump inhibitors and prognosis of cirrhosis - searching for the balance point
    Schiavon, L. L.
    Silva, T. E.
    Fischer, J.
    Narciso-Schiavon, J. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (02) : 378 - 379
  • [29] Proton pump inhibitors: perspectives of patients and their GPs
    Grime, J
    Pollock, K
    Blenkinsopp, A
    BRITISH JOURNAL OF GENERAL PRACTICE, 2001, 51 (470): : 703 - 711
  • [30] Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding
    Hung, Tsung-Hsing
    Lee, Hsing-Feng
    Tseng, Chih-Wei
    Tsai, Chih-Chun
    Tsai, Chen-Chi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (04) : 353 - 359
12345